Impact of USCAST proposed breakpoint changes to aminoglycosides, cyclines, and levofoxacin on carbapenem-resistant enterobacteriaceae at a US tertiary referral academic medical center

Category Primary study
JournalOpen Forum Infect. Dis.
Year 2018
This article has no abstract
Epistemonikos ID: f98c86525f69e3623ef6253d8ab868a378e251e2
First added on: Jun 04, 2021